Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Methods ; 23(4): 313-23, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11316432

ABSTRACT

The following protocol is for radioactive in situ hybridization detection of RNA using paraffin-embedded tissue sections on glass microscope slides. Steps taken to inhibit RNase activity such as diethyl pyrocarbonate (DEPC) treatment of solutions and baked glassware are unnecessary. The tissue is fixed using 4% paraformaldehyde, hybridized with (35)S-labeled RNA probes, and exposed to nuclear-track emulsion. The entire procedure takes 2-3 days prior to autoradiography. The time required for autoradiography is variable with an average time of 10 days. Parameters that affect the length of the autoradiography include: (1) number of copies of mRNA in the tissue, (2) incorporation of label into the probe, and (3) amount of background signal. Additional steps involved in the autoradiography process, including development of the emulsion, cleaning of the microscope slides, counterstaining of the tissue, and mounting coverslips on the microscope slides, are discussed. In addition, a general guide to the interpretation of the in situ results is provided.


Subject(s)
In Situ Hybridization/methods , Molecular Probes , Sulfur Radioisotopes/pharmacology , Acetic Anhydrides/pharmacology , Animals , Diethyl Pyrocarbonate/pharmacology , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Embryo, Nonmammalian , Endopeptidase K/metabolism , Ethanolamines/pharmacology , Nucleic Acid Hybridization , Paraffin/chemistry , RNA, Messenger/metabolism , Ribonucleases/metabolism , Time Factors
2.
Cytogenet Cell Genet ; 94(3-4): 155-62, 2001.
Article in English | MEDLINE | ID: mdl-11856873

ABSTRACT

Down Syndrome (DS) is a major cause of mental retardation and is associated with characteristic well-defined although subtle brain abnormalities, many of which arise after birth, with particular defects in the cortex, hippocampus and cerebellum. The neural cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule) maps to 21q22.2-->q22.3, a region associated with DS mental retardation, and is expressed largely in the neurons of the central and peripheral nervous systems during development. In order to evaluate the contribution of DSCAM to postnatal morphogenetic and cognitive processes, we have analyzed the expression of the mouse DSCAM homolog, Dscam, in the adult mouse brain from 1 through 21 months of age. We have found that Dscam is widely expressed in the brain throughout adult life, with strongest levels in the cortex, the mitral and granular layers of the olfactory bulb, the granule cells of the dentate gyrus and the pyramidal cells of the CA1, CA2 and CA3 regions, the ventroposterior lateral nuclei of the thalamus, and in the Purkinje cells of the cerebellum. Dscam is also expressed ventrally in the adult spinal cord. Given the homology of DSCAM to cell adhesion molecules involved in development and synaptic plasticity, and its demonstrated role in axon guidance, we propose that DSCAM overexpression contributes not only to the structural defects seen in these regions of the DS brain, but also to the defects of learning and memory seen in adults with DS.


Subject(s)
Aging/genetics , Brain/metabolism , Conserved Sequence/genetics , Down Syndrome/genetics , Gene Expression Profiling , Mice/genetics , Proteins/genetics , Amino Acid Sequence , Animals , Brain/cytology , Brain/embryology , Brain/growth & development , Cell Adhesion Molecules , Gene Expression Regulation, Developmental , Humans , In Situ Hybridization , Membrane Proteins , Molecular Sequence Data , Morphogenesis , Protein Structure, Tertiary , Proteins/chemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Homology, Amino Acid , Spinal Cord/metabolism
3.
Circ Res ; 86(9): 932-8, 2000 May 12.
Article in English | MEDLINE | ID: mdl-10807864

ABSTRACT

Jumonji (jmj) was cloned in a gene trap screen to identify and mutagenize genes important for heart development. To investigate the role of jmj in heart development, we generated mice homozygous for the jmj mutation. The jmj homozygous mouse embryos showed heart malformations, including ventricular septal defect, noncompaction of the ventricular wall, double-outlet right ventricle, and dilated atria. The jmj mutants died soon after birth, apparently as a result of respiratory insufficiency caused by rib and sternum defects in addition to the heart defects. In situ hybridization analyses suggested that cardiomyocytes were differentiated but developmental regulation of chamber-specific genes was defective in fetal hearts. Expression of jmj was detected in the myocardium, especially in the interventricular septum, ventricular wall, and outflow tract, which correlated well with the locations of defects observed in the hearts of mutant mice. Homozygous embryos failed to express the jmj transcript in all tissues except in the nervous system. Confocal microscopic examination using anti-JMJ antibodies indicated that the JMJ protein was localized in the nuclei of cells transfected with jmj. These data demonstrate that JMJ is a nuclear protein, which is essential for normal heart development and function.


Subject(s)
Heart/embryology , Nerve Tissue Proteins/physiology , Animals , Biomarkers , Embryo, Mammalian/physiology , Gene Expression , Genotype , Heart Defects, Congenital/genetics , Heart Defects, Congenital/metabolism , Heart Defects, Congenital/pathology , Homozygote , Mice , Mice, Knockout/genetics , Mice, Mutant Strains/genetics , Mutation , Myocardium/metabolism , Myocardium/pathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nervous System/metabolism , Nuclear Proteins/physiology , Polycomb Repressive Complex 2 , Tissue Distribution
4.
Eur J Neurosci ; 10(4): 1383-93, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9749792

ABSTRACT

The kinesin-related motor protein CHO1/MKLP1 was initially thought to be expressed only in mitotic cells, where it presumably transports oppositely oriented microtubules relative to one another in the spindle mid-zone. We have recently shown that CHO1/MKLP1 is also expressed in cultured neuronal cells, where it is enriched in developing dendrites [Sharp et al. (1997a) J. Cell Biol., 138, 833-843]. The putative function of CHO1/MKLP1 in these postmitotic cells is to intercalate minus-end-distal microtubules among oppositely oriented microtubules within developing dendrites, thereby establishing their non-uniform microtubule polarity pattern. Here we used in situ hybridization to determine whether CHO1/MKLP1 is expressed in a variety of rodent neurons both in vivo and in vitro. These analyses revealed that CHO1/MKLP1 is expressed within various neuronal populations of the brain including those in the cerebral cortex, hippocampus, olfactory bulb and cerebellum. The messenger ribonucleic acid (mRNA) levels are high within these neurons well after the completion of their terminal mitotic division and throughout the development of their dendrites. After this, the levels decrease and are relatively low within the adult brain. Parallel analyses on developing hippocampal neurons in culture indicate that the levels of expression increase dramatically just prior to dendritic development, and then decrease somewhat after the dendrites have differentiated. Dorsal root ganglion neurons, which generate axons but not dendrites, express significantly lower levels of mRNA for CHO1/MKLP1 than hippocampal or sympathetic neurons. These results are consistent with the proposed role of CHO1/MKLP1 in establishing the dendritic microtubule array.


Subject(s)
Antigens/genetics , Gene Expression Regulation, Developmental/physiology , Microtubule-Associated Proteins/genetics , Mitosis/genetics , Nerve Tissue Proteins/genetics , Neurons/metabolism , Animals , Blotting, Northern , Brain/cytology , Brain/metabolism , Cells, Cultured , Cricetinae , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , In Situ Hybridization , Neurons/cytology , Rats
5.
Am J Pathol ; 151(2): 633-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9250174

ABSTRACT

Arenaviruses present an emerging health threat in agrarian areas of Africa and South America; however, the natural routes of arenaviral infections are not clearly understood. Our previous studies with lymphocytic choriomeningitis virus (LCMV), the prototype arenavirus, implicate oral and intragastric routes as natural routes of infection. Our studies raised many questions about the primary site of infection and the route of dissemination after gastric infection. In this report, we use in situ hybridization to detect LCMV in various organs at different time points (0 to 96 hours). After gastric inoculation, the gastric mucosa is the initial site of viral infection, followed by infection of the spleen and liver, then ileum and last, lung, kidney, brain, and esophagus. Furthermore, our observations suggest that virus is disseminated lymphatically rather than by a hematogenous route. Infectious center assays using mononuclear cells from stomach, blood, and spleen of mice infected by the gastric route confirmed active infection with LCMV and the presence of mononuclear cells producing infectious virus in these tissues. This is the first identification of gastric epithelia as a primary site of virus infection.


Subject(s)
Disease Models, Animal , Lymphocytic Choriomeningitis/virology , Lymphocytic choriomeningitis virus , Animals , In Situ Hybridization , Male , Mice , Mice, Inbred BALB C , Stomach/virology , Time Factors , Tissue Distribution
6.
Dev Biol ; 185(2): 201-14, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9187083

ABSTRACT

We have developed an in vitro gene trap screen for novel murine genes that allows one to determine, prior to making chimeric or transgenic animals, if these genes are expressed in one or more specific embryonic tissues. Totipotent embryonic stem (ES) cells are infected with a retroviral gene trap construct encoding a selectable lacZ/neo fusion gene, which is expressed only if the gene trap inserts within an active transcription unit. G418-resistant ES cell clones are induced to differentiate in vitro, and neurons, glia, myocytes, and chondrocytes are screened for expression of beta-galactosidase (beta-gal). cDNAs of the gene trap transcripts are obtained by 5' rapid amplification of cDNA ends and are sequenced to determine if they represent novel genes. In situ hybridization analyses show that trapped genes are expressed in vivo within the cell types that express beta-gal in vitro. Gene traps and their wild-type alleles are characterized in terms of copy number, alternate splicing of their transcripts, and the proportion of endogenous mRNA sequence that is replaced by lacZ/neo in the hybrid gene trap transcript. This approach, which we term "in vitro preselection," is more economical than standard in vivo gene trap screening because tissue-specific expression of probable knockout alleles is verified before transgenic animals are generated. These results also highlight the utility of ES cell differentiation in vitro as a method with which to study the molecular mechanisms regulating the specification and commitment of a variety of cell and tissue types.


Subject(s)
Gene Expression Regulation, Developmental , Gene Transfer Techniques , Stem Cells , beta-Galactosidase/genetics , Animals , Base Sequence , Cartilage/enzymology , Cells, Cultured , Clone Cells , DNA Primers/chemistry , Fluorescent Antibody Technique, Indirect , In Situ Hybridization , Mice , Molecular Sequence Data , Muscle, Skeletal/enzymology , Neuroglia/enzymology , Neurons/enzymology , beta-Galactosidase/metabolism
7.
Circ Res ; 78(3): 379-87, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8593696

ABSTRACT

To explore the compatibility of skeletal and cardiac programs of gene expression, transgenic mice that express a skeletal muscle myogenic regulator, bmyf5, in the heart were analyzed. These mice develop a severe cardiomyopathy and exhibit a significantly shorter life span than do their nontransgenic littermates. The transgene was expressed from day 7.5 post coitum forward, resulting in activation of skeletal muscle genes not normally seen in the myocardium. Cardiac pathology was not apparent at midgestation but was evident by day 2 of postnatal life, and by 42 days, hearts exhibited multifocal interstitial inflammation, fibrosis, cellular hypertrophy, and occasional myocyte degeneration. All four chambers of the heart were enlarged to varying degrees, with the atria demonstrating the most significant hypertrophy (>100% in 42-day-old mice). The transgene and several skeletal muscle-specific genes were expressed only in patchy areas of the heart in heterozygous mice. However, molecular markers of hypertrophy (such as alpha-skeletal actin and atrial myosin light chain- 1) were expressed with a wider distribution, suggesting that their induction was secondary to the expression of the transgene, In older (28-week-old) mice, lung weights were also significantly increased, consistent with congestive heart failure. The life span of bmyf5 mice was significantly shortened, with an average life span of 109 days, compared with at least a twofold longer life expectancy for nontransgenic littermates. Expression of the transgene was associated with an increase in Ca2+-stimulated myofibrillar ATPase in myofibrils obtained from the left ventricles of 42-day-old bmyf5 mice. Myocardial bmyf5 expression therefore induces a program of skeletal muscle gene expression that results in progressive cardiomyopathy that may be due to incompatibility of heart and skeletal muscle structural proteins.


Subject(s)
Cardiomyopathies/genetics , DNA-Binding Proteins , Muscle Proteins/genetics , Myocardium/metabolism , Myogenic Regulatory Factors/genetics , Trans-Activators , Transcription Factors/genetics , Age Factors , Animals , Animals, Newborn , Base Sequence , Cardiomyopathies/embryology , Cardiomyopathies/pathology , Fetal Heart/metabolism , Fetal Heart/pathology , Fetal Heart/ultrastructure , Gene Expression , In Situ Hybridization , Mice , Mice, Transgenic , Microscopy, Electron , Molecular Sequence Data , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscle, Skeletal/ultrastructure , Myocardium/pathology , Myocardium/ultrastructure , Myogenic Regulatory Factor 5 , Organ Size , Transgenes
8.
Dev Dyn ; 204(3): 291-300, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8573720

ABSTRACT

Overexpression of either v-ski, or the proto-oncogene, c-ski, in quail embryo fibroblasts induces the expression of myoD and myogenin, converting the cells to myoblasts capable of differentiating into skeletal myotubes. In transgenic mice, overexpression of ski also influences muscle development, but in this case it effects fully formed muscle, causing hypertrophy of fast skeletal muscle fibers. In attempts to determine whether endogenous mouse c-ski plays a role in either early muscle cell determination or late muscle cell differentiation, we analyzed mRNA expression during muscle development in mouse embryos and during in vitro terminal differentiation of skeletal myoblasts. To generate probes for these studies we cloned coding and 3' non-coding regions of mouse c-ski. In situ hybridization revealed low c-ski expression in somites, and only detected elevated levels of mRNA in skeletal muscle beginning at about 12.5 days of gestation. Northern analysis revealed a two-fold increase in c-ski mRNA during terminal differentiation of skeletal muscle cell lines in vitro. Our results suggest that c-ski plays a role in terminal differentiation of skeletal muscle cells not in the determination of cells to the myogenic lineage.


Subject(s)
DNA-Binding Proteins/genetics , Muscle, Skeletal/embryology , Proto-Oncogene Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Differentiation/genetics , Cell Line/physiology , Cloning, Molecular , Conserved Sequence , Exons/genetics , Gene Expression Regulation, Developmental/physiology , In Situ Hybridization , Mice , Molecular Sequence Data , Muscle, Skeletal/cytology , Muscle, Skeletal/physiology , RNA, Messenger/analysis
9.
J Neurosci ; 15(8): 5727-38, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7643214

ABSTRACT

Members of the myocyte enhancer factor 2 (MEF2) gene family are expressed in a dynamic pattern during development of the CNS of pre- and postnatal mice. The four MEF2 genes, Mef2A, -B, -C, -D, encode transcription factors belonging to the MADS (MCM1-agamous-deficiens-serum response factor) superfamily of DNA binding proteins. MEF2 factors have previously been shown to be positive regulators of gene expression in terminally differentiated muscle cells. To begin to determine the role of MEF2 factors in CNS development, we used in situ hybridization with gene-specific cRNA probes to define the expression patterns of each of the four Mef2 mRNAs in the developing and mature mouse CNS. Mef2C mRNA was first detected in a ventral portion of the telencephalon at 11.5 d postcoitum (p.c.). By 13.5 d p.c., each of the four Mef2 genes were expressed in overlapping yet distinct patterns in regions of the frontal cortex, midbrain, thalamus, hippocampus, and hindbrain. Temporal and spatial patterns of embryonic Mef2 gene expression appeared to follow gradients of neuron maturation and suggested that the onset of Mef2 gene expression coincides with withdrawal from the cell cycle and initiation of neuronal differentiation. This correlation is particularly striking for Purkinje cells in the cerebellum. Since the molecular mechanisms that regulate neuron differentiation are unknown, we propose that the MEF2 factors are likely to play an important role in this process.


Subject(s)
Central Nervous System/physiology , DNA-Binding Proteins/genetics , Gene Expression , Neurons/physiology , Transcription Factors/genetics , Animals , Animals, Newborn/physiology , Brain/physiology , Cellular Senescence , MEF2 Transcription Factors , Mice , Myogenic Regulatory Factors , Neural Crest/physiology , RNA, Messenger/metabolism
10.
Dev Dyn ; 201(4): 354-65, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7894074

ABSTRACT

The cellular protooncogene, c-ski, is expressed in all cells of the developing mouse at low but detectable levels. In situ hybridization and Northern blot analyses reveal that some cells and tissues express this gene at higher levels at certain stages of embryonic and postnatal development. RT-PCR results indicate that alternative splicing of exon 2, known to occur in chickens (Sutrave and Hughes [1989] Mol. Cell. Biol. 9:4046-4051; Grimes et al. [1993] Oncogene 8:2863-2868) does not occur in adult mouse tissues. In the embryo, neural crest cells express the c-ski gene during migration at 8.5 to 9.5 days post coitum (p.c.). Neural crest derivatives such as dorsal root ganglia and melanocytes stain positively with an antibody to the ski protein. At 9 days p.c., the entire neural tube has high levels of c-ski gene expression. By 12-13.5 days only the ependymal layer expresses c-ski above background levels. At 14-16 days p.c., c-ski mRNAs are detected at high levels in the cortical layers of the brain and in the olfactory bulb. In 2 week and 6 week postnatal brains, c-ski gene transcripts are also detected in the hippocampus and in the granule cell layer of the cerebellum. The allantois and placenta exhibit high levels of c-ski mRNAs. Neonatal lung tissue increases c-ski gene expression approximately two-fold compared to prenatal levels. These results suggest that ski plays a role in both the proliferation and differentiation of specific cell populations of the central and peripheral nervous systems and of other tissues.


Subject(s)
DNA-Binding Proteins/genetics , Neurons/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogenes , Alternative Splicing , Animals , Base Sequence , Cell Division , Central Nervous System/embryology , Central Nervous System/metabolism , DNA Primers/genetics , Exons , Gene Expression Regulation, Developmental , Gestational Age , In Situ Hybridization , Mice , Mitosis , Molecular Sequence Data , Neurons/cytology , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Respiratory System/embryology , Respiratory System/metabolism
11.
Curr Eye Res ; 13(10): 755-63, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7531130

ABSTRACT

Components of the Renin Angiotensin System (RAS) have been detected in ocular tissues and fluids. The source of the ocular RAS proteins is unknown but possibilities include diffusion or leakage from the systemic circulation, specific uptake from the blood, or local synthesis. We have used RT-PCR and in situ hybridization (ISH) to show that renin mRNA is present in ocular tissues from 3 strains of rats. By RT-PCR, we found 10 of 15 ciliary body samples, 13 of 16 iris samples, and 1 of 3 retina samples were positive for renin mRNA. Also, 6 of 6 brain and 7 of 8 kidney samples were positive. Using ISH, we found renin mRNA in the ciliary muscle adjacent to the sclera extending into the choroid. Tissue near the outflow channels of the anterior chamber angle also labeled. Retinal labeling was weak but present in the nerve fiber layer. Clusters of grains, possibly representing blood vessels, were also seen in the ciliary body, iris, and retina using ISH. These results suggest the presence of a local ocular RAS.


Subject(s)
Eye/metabolism , RNA, Messenger/biosynthesis , Renin/biosynthesis , Animals , Base Sequence , Brain/metabolism , DNA Primers , In Situ Hybridization , Kidney/metabolism , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA-Directed DNA Polymerase , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Rats, Sprague-Dawley , Renin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...